Carisoprodol Tablet
Product Images NDC 72189-310

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 72189-310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Directrx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fhtyfgh (72189 310 30)

Fhtyfgh (72189 310 30)
The packaging label for Carisoprodol C-IV oral tablets displays the strength as 350 mg per tablet, with a quantity of 30 tablets in the package. The label identifies the generic form as Soma and notes Carisoprodol USP 350 mg per tablet. It includes the NDC number 72189-310-30 and packaging details by DirectRx. Lot and expiration dates are also visible on the label.*
FDA Label Image

Yhght (72189 310 90)

Yhght (72189 310 90)
CARISOPRODOL C-IV 350 mg oral tablets in a blister pack containing 90 tablets. The label is yellow and white with black text, showing the generic brand name Carisoprodol and the brand name Soma. Packaged and distributed by DirectRx, the label includes lot number 06JA2210 and expiration date 08/31/23.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.